$INO This news is flying in Korea right now. News came out around three hours ago. For the first time in the world, Geneone Life science has completed a 2nd phase human trial for MERS vaccine and have submitted the result to KFDA. The efficacy rate was 92% after two doses, and even better in the three dosage group. hankyung.com/it/article/202...
  • 12
  • 1
12 Likes